Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.32 |
| ▸ | NOX1 | Q9Y5S8 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19253139 | 0.87 | NPC1 (0.37) | NPC1RAB9ALMNAL3MBTL1MAPT | |
| SCHEMBL19253126 | 0.83 | NPC1 (0.35) | NPC1RAB9ALMNAL3MBTL1MAPT | |
| SCHEMBL17559563 | 0.82 | NOX1 (0.38) | LMNAL3MBTL1MAPTNOX1MAPK1 | |
| SCHEMBL5358787 | 0.79 | MAPT (0.46) | NPC1RAB9ALMNAL3MBTL1MAPT | |
| SCHEMBL17559556 | 0.77 | NPC1 (0.40) | NPC1RAB9AMAPTCTNNB1TDP1 | |
| SCHEMBL17559560 | 0.75 | PTGS1 (0.34) | CTNNB1ALOX5 | |
| SCHEMBL17559571 | 0.75 | GAA (0.49) | NPC1RAB9ALMNAL3MBTL1MAPT | |
| SCHEMBL9778273 | 0.74 | NOX1 (0.40) | NPC1RAB9ALMNAL3MBTL1MAPT | |
| SCHEMBL19268227 | 0.72 | NPC1 (0.32) | NPC1RAB9ALMNAL3MBTL1MAPT | |
| SCHEMBL14468403 | 0.72 | CYP2A6 (0.49) | NPC1RAB9ALMNAL3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3189083-B2 | POLYCYCLIC PHOTOINITIATORS | IGM GROUP B V (NL) | 2023-07-05 | — | — | EP | disclosed |
| EP-3189083-B2 | POLYCYCLIC PHOTOINITIATORS | IGM GROUP B V (NL) | 2023-07-05 | — | — | EP | disclosed |
| EP-3189083-B1 | POLYCYCLIC PHOTOINITIATORS | IGM GROUP B V (NL) | 2020-04-08 | — | — | EP | disclosed |
| CN-107075000-B | Polycyclic photoinitiators | IGM集团公司 | 2020-01-31 | — | — | CN | disclosed |
| US-10113075-B2 | Polycyclic photoinitiators | IGM MALTA LIMITED (MT) | 2018-10-30 | — | — | US | disclosed |
| US-20170240755-A1 | POLYCYCLIC PHOTOINITIATORS | IGM GROUP B.V. (NL) | 2017-08-24 | — | — | US | disclosed |
| US-20170240755-A1 | POLYCYCLIC PHOTOINITIATORS | IGM GROUP B.V. (NL) | 2017-08-24 | — | — | US | disclosed |
| US-20170240755-A1 | POLYCYCLIC PHOTOINITIATORS | IGM GROUP B.V. (NL) | 2017-08-24 | — | — | US | disclosed |
| EP-3189083-A1 | POLYCYCLIC PHOTOINITIATORS | IGM Malta Limited (MT) | 2017-07-12 | — | — | EP | disclosed |
| WO-2016034963-A1 | POLYCYCLIC PHOTOINITIATORS | BASF SE (DE) | 2016-03-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170240755-A1 | POLYCYCLIC PHOTOINITIATORS | C1R, C9, C5 | NPC1 3719/4885RAB9A 1172/4885LMNA 2538/4885 |
| US-10113075-B2 | Polycyclic photoinitiators | C1R, C9, C5 | NPC1 3723/4885RAB9A 1190/4885LMNA 2550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.